CGL5 5mg*10vials

Cagrilintide CGL5 5mg*10vials

Cagrilintide is an amylin analog research peptide designed to modulate appetite and satiety signaling pathways, representing a specialized metabolic research compound.

The 5mg single-vial specification is the standard concentration, ideal for initial amylin pathway studies, dose-response experiments, and researchers conducting foundational satiety mechanism research. This concentration offers flexibility in experimental design, allowing researchers to explore various dose levels while studying appetite regulation pathways.

Through amylin receptor activation, Cagrilintide supports research into satiety signaling, food intake regulation, and appetite-related metabolic pathways. It is designed to investigate how amylin pathway modulation can influence appetite control and metabolic homeostasis research applications.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Each batch undergoes rigorous purity testing, with a certificate of analysis provided.

10 vials per pack, suitable for foundational laboratory research and appetite regulation mechanism studies.